Phosphorylated Twist1 and cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120213801A1
SERIAL NO

13504981

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present application relates to methods for treating cancer in a subject by modulating the phosphorylation of the Serine 42 of Twist1 by administering to said subject a therapeutically effective amount of a modulator of said phosphorylation of the Serine 42 of Twist1. Antibodies, uses methods and biomarkers based on the phosphorylation of the Serine 42 of Twist1 are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH4058 BASEL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gresko, Ekaterina Zurich, CH 1 0
Hemmings, Brian Arthur Bettingen, CH 18 30
Vychalkovskiy, Anton Zurich, CH 1 0
Xue, Gongda Allschwil, CH 5 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation